ResearcherUniversity of KansasNo recent work listed
Jeanne Drisko
Matched on ORCID iD 0000-0001-7187-3368; OpenAlex author ID A5065701833. Sources: ClinicalTrials.gov.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 1 (principal investigator on 1)
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper, 1 trial · 2012: none · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper
Papers 5
- Treatment of pancreatic cancer with intravenous vitamin C: a case report. Co-author DOI 10.1097/cad.0000000000000603↗
- High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study. Co-author DOI 10.1038/s41598-017-17568-8↗
- Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): results from a phase I clinical trial. Co-author DOI 10.1007/s00280-013-2070-8↗
- Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira. First author DOI 10.3892/or.2013.2461↗
- Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Co-author DOI 10.1016/j.freeradbiomed.2011.03.007↗
Trials 1
- New Treatment Option for Pancreatic Cancer Principal investigator NCT01364805↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mark Levine · 4 shared papers, 2011–2018 · strength 0.23
- Paper Treatment of pancreatic cancer with intravenous vitamin C: a case report. DOI 10.1097/cad.0000000000000603↗
- Paper High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study. DOI 10.1038/s41598-017-17568-8↗
- Paper Pharmacological ascorbate with gemcitabine for the control of metastatic and node-positive pancreatic cancer (PACMAN): … DOI 10.1007/s00280-013-2070-8↗
- Qi Chen · 2 shared papers, 2011–2017 · strength 0.09
- Kishore Polireddy · 1 shared paper, 2017 · strength 0.06
- Fang Fan · 1 shared paper, 2017 · strength 0.06
- Ping Chen · 1 shared paper, 2017 · strength 0.06
- Jun Yu · 1 shared paper, 2017 · strength 0.06
- Ruochen Dong · 1 shared paper, 2017 · strength 0.06
- Qi Chen · 1 shared paper, 2013 · strength 0.06
- Jun Yu · 1 shared paper, 2013 · strength 0.06
- Daniel Berg · 1 shared paper, 2013 · strength 0.03
- Jessemae L. Welsh · 1 shared paper, 2013 · strength 0.03
- Thorvardur Ragnar Halfdanarson · 1 shared paper, 2013 · strength 0.03
- Garry R. Buettner · 1 shared paper, 2013 · strength 0.03
- Kellie L. Bodeker · 1 shared paper, 2013 · strength 0.03
- Juan Du · 1 shared paper, 2013 · strength 0.03
- Nelson S. Yee · 1 shared paper, 2013 · strength 0.03
- Joseph J. Cullen · 1 shared paper, 2013 · strength 0.03
- Michael Graham Espey · 1 shared paper, 2011 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.